Valeo Financial Advisors LLC Has $311,000 Position in CVS Health (CVS)

Valeo Financial Advisors LLC increased its stake in shares of CVS Health (NYSE:CVS) by 119.4% during the 4th quarter, HoldingsChannel.com reports. The fund owned 4,294 shares of the pharmacy operator’s stock after purchasing an additional 2,337 shares during the quarter. Valeo Financial Advisors LLC’s holdings in CVS Health were worth $311,000 as of its most recent filing with the Securities & Exchange Commission.

A number of other institutional investors also recently bought and sold shares of the stock. Wealthcare Advisory Partners LLC boosted its position in CVS Health by 330.3% during the third quarter. Wealthcare Advisory Partners LLC now owns 1,291 shares of the pharmacy operator’s stock worth $105,000 after purchasing an additional 991 shares in the last quarter. Fieldpoint Private Securities LLC boosted its position in CVS Health by 333.3% during the second quarter. Fieldpoint Private Securities LLC now owns 1,300 shares of the pharmacy operator’s stock worth $105,000 after purchasing an additional 1,000 shares in the last quarter. Arcadia Investment Management Corp MI boosted its position in CVS Health by 119.6% during the third quarter. Arcadia Investment Management Corp MI now owns 1,333 shares of the pharmacy operator’s stock worth $108,000 after purchasing an additional 726 shares in the last quarter. MPS Loria Financial Planners LLC purchased a new position in CVS Health during the second quarter worth approximately $119,000. Finally, Cerebellum GP LLC purchased a new position in CVS Health during the fourth quarter worth approximately $130,000. 83.97% of the stock is currently owned by hedge funds and other institutional investors.

CVS has been the topic of a number of recent analyst reports. Tigress Financial reiterated a “buy” rating on shares of CVS Health in a research report on Tuesday, December 26th. ValuEngine downgraded CVS Health from a “buy” rating to a “hold” rating in a research report on Sunday, December 31st. Needham & Company LLC increased their price target on CVS Health from $85.00 to $88.00 and gave the stock a “buy” rating in a research report on Tuesday, January 2nd. UBS upgraded CVS Health from an “outperform” rating to a “strong-buy” rating in a research report on Thursday, January 4th. Finally, Raymond James Financial upgraded CVS Health from an “outperform” rating to a “strong-buy” rating and set a $90.00 price target on the stock in a research report on Thursday, January 4th. They noted that the move was a valuation call. Two investment analysts have rated the stock with a sell rating, seven have assigned a hold rating, twelve have issued a buy rating and two have assigned a strong buy rating to the company. The stock has an average rating of “Buy” and a consensus price target of $86.65.



In other news, EVP Helena Foulkes sold 19,965 shares of the firm’s stock in a transaction that occurred on Friday, February 16th. The stock was sold at an average price of $71.04, for a total value of $1,418,313.60. Following the transaction, the executive vice president now owns 65,072 shares in the company, valued at $4,622,714.88. The transaction was disclosed in a document filed with the SEC, which is accessible through this hyperlink. Company insiders own 0.61% of the company’s stock.

NYSE CVS opened at $64.00 on Friday. The company has a market capitalization of $63,986.53, a PE ratio of 10.65, a PEG ratio of 1.04 and a beta of 1.05. CVS Health has a 1-year low of $60.14 and a 1-year high of $84.00. The company has a current ratio of 1.02, a quick ratio of 0.52 and a debt-to-equity ratio of 0.59.

CVS Health (NYSE:CVS) last released its earnings results on Thursday, February 8th. The pharmacy operator reported $1.92 earnings per share for the quarter, beating the consensus estimate of $1.88 by $0.04. The business had revenue of $48.39 billion for the quarter, compared to the consensus estimate of $47.54 billion. CVS Health had a return on equity of 17.21% and a net margin of 3.58%. The business’s quarterly revenue was up 5.3% compared to the same quarter last year. During the same quarter last year, the business posted $1.71 earnings per share. research analysts predict that CVS Health will post 6.31 earnings per share for the current fiscal year.

The company also recently announced a quarterly dividend, which will be paid on Thursday, May 3rd. Stockholders of record on Monday, April 23rd will be given a $0.50 dividend. The ex-dividend date of this dividend is Friday, April 20th. This represents a $2.00 annualized dividend and a dividend yield of 3.13%. CVS Health’s dividend payout ratio (DPR) is presently 33.90%.

WARNING: “Valeo Financial Advisors LLC Has $311,000 Position in CVS Health (CVS)” was originally posted by Dakota Financial News and is owned by of Dakota Financial News. If you are viewing this article on another domain, it was illegally stolen and republished in violation of international copyright & trademark legislation. The original version of this article can be accessed at https://dakotafinancialnews.com/2018/04/13/valeo-financial-advisors-llc-has-311000-position-in-cvs-health-cvs.html.

CVS Health Profile

CVS Health Corporation, together with its subsidiaries, provides integrated pharmacy health care services. It operates through Pharmacy Services and Retail/LTC segments. The Pharmacy Services segment offers pharmacy benefit management solutions, such as plan design and administration, formulary management, Medicare Part D services, mail order, specialty pharmacy and infusion services, retail pharmacy network management services, prescription management systems, clinical services, disease management programs, and medical pharmacy management services.

Want to see what other hedge funds are holding CVS? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for CVS Health (NYSE:CVS).

Institutional Ownership by Quarter for CVS Health (NYSE:CVS)

Receive News & Ratings for CVS Health Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for CVS Health and related companies with MarketBeat.com's FREE daily email newsletter.

Leave a Reply